Assessing the effects of racemic and single-enantiomer albuterol on airway secretions in long-term intubated patients

Chest

Volumn 129, Issue 1, 2006, Pages 124-132

  O'Riordan, Thomas G ^a   Mao, Wenyang ^b   Palmer, Lucy B ^b   Chen, John J ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

Albuterol; Hypersecretion; Levalbuterol; Tracheobronchitis; 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BICARBONATE; CELL ADHESION MOLECULE; ELECTROLYTE; INTERLEUKIN 1BETA; INTERLEUKIN 8; PLACEBO; SALBUTAMOL; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASPIRATION; BRONCHUS SECRETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; DRUG WITHDRAWAL; ENANTIOMER; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INFLAMMATION; MALE; MUCOCILIARY CLEARANCE; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 33144460423     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.1.124     Document Type: Article

References (33)

1. Barnes PJ. β-Adrenergic receptor and their regulation. Am J Respir Crit Care Med 1995; 152:838-860
2. Agrawal DK, Ariyarathna K, Kelbe PW. (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells. J Allergy Clin Immunol 2004; 113:503-510
3. Berger WE. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma. Ann Allergy Asthma Immunol 2003; 90:583-591
4. Nowak RM, Emerman CL, Schaefer K, et al. Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study. Am J Emerg Med 2004; 22:29-36
5. Frohock J, Wijkstrom-Frei C, Salathe M. Effects of albuterol enantiomers on ciliary beat frequency in ovine tracheal epithelial cells. J Appl Physiol 2002; 92:2396-4026
6. Salathe M, O'Riordan TG, Wanner A. Treatment of mucociliary dysfunction. Chest 1996; 110:1048-1057
7. Wanner A, Salathe M, O'Riordan TG. State of the art: mucociliary dysfunction in airways disease. Am J Respir Crit Care Med 1996; 154:1868-1902
8. Boucher RC. Human airway ion transport I and II. Am J Respir Crit Care Med 1994; 150:271-281; 581-593
9. + across the trachea of the dog. Am Rev Respir Dis 1979; 120:547-552
10. Hanania NA, Darken P, Horstman D, et al. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest 2003; 124:834-843
11. Bennett WD. Effect of β-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol 2002; 110(6 Suppl):S291-S297
12. Sutton PP, Gemmell HG, Innes N, et al. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy. Thorax 1988; 43:57-60
13. Pulmonzyme prescribing information [package insert]. South San Francisco, CA: Genentech, January 2001
14. Niederman MS, Ferranti RD, Zeigler A, et al. Respiratory infection complicating long-term tracheostomy: the implication of persistent Gram-negative tracheobronchial colonization. Chest 1984; 85:39-44
15. Palmer LB, Smaldone GC, Simon SR, et al. Tracheal aspirates in chronically mechanically ventilated patients: a human model of gram-negative infection and airway inflammation. Chest 1995; 108:1326-1332
16. Palmer LB, Smaldone GC, O'Riordan TG, et al. Aerosolized antibiotics in mechanically ventilated patients: delivery and response. Crit Care Med 1998; 26:31-39
17. Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation: comparison of MDI and nebulizer efficiency. Am J Respir Crit Care Med 1995; 152:1391-1394
18. O'Riordan TG, Palmer LB, Smaldone GC. Aerosol deposition in mechanically ventilated patients: optimizing nebulizer delivery. Am J Respir Crit Care Med 1994; 149:214-219
19. Miller DD, Amin MM, Palmer LB, et al. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med 2003; 168:1205-1209
20. Diggle PJ, Heagety P, Liang, K-Y, et al. Analysis of longitudinal data. 2nd ed. New York, NY: Oxford University Press, 2002
21. Dhand R, Jubran A, Tobin MJ. Bronchodilator delivery by metered dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 1995; 151:1827-1833
22. Bennett WD, Chapman WP, Lay JC, et al. Pulmonary clearance of inhaled particles 24 to 48 hours post deposition: effect of β-adrenergic stimulation. J Aerosol Med 1993; 6:53-62
23. Boe J, Dennis J, O'Driscoll BR. European Respiratory Society guidelines on the use of nebulizers. Eur Respir J 2001; 18:228-242
24. Messina MS, O'Riordan TG, Smaldone GC. Changes in mucociliary clearance during acute exacerbations of asthma. Am Rev Respir Dis 1991; 143:993-997
25. Dhand R, Goode M, Reid R, et al. Preferential pulmonary retention of S-albuterol after inhalation of racemic albuterol. Am J Respir Crit Care Med 1999; 160:1136-1141
26. Isawa T, Teshima T, Hirano T, et al. Effect of bronchodilation on the deposition and clearance of radioaerosol in bronchial asthma in remission J Nuclear Med 1987; 28:1901-1902
27. Guleria R, Singh TR, Sinha S, et al. Effect of single inhalation of a salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic obstructive airway disease. Indian J Chest Dis Allied Sci 2003; 45:241-246
28. Perry RJ, Smaldone GC. Effect of bronchodilators on mucociliary clearance in normal adults. J Aerosol Med 1990; 3:187-196
29. Hasani A, Toms N, O'Connor J, et al. Effect of salmeterol xinafoate on lung mucociliary clearance in patients with asthma. Respir Med 2003; 97:667-671
30. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988; 169
31. Potter JL, Matthews LW, Spector S, et al. Studies on pulmonary secretions II: osmolarity and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis and laryngectomy. Am Rev Respir Dis 1967; 96:83-87
32. Joris L, Quinton PM. Concentration of elements in airway surface fluid. Med Sci Res 1987; 15:855-856
33. O'Riordan TG, Weinstein MD, Abraham WM, et al. Elevated tissue kallikrein activity in airway secretions from patients with tracheobronchitis associated with prolonged mechanical ventilation. Lung 2003; 181:237-244